Greater ease in performing complex surgical maneuvers, reduction of bleeding and the need for transfusions, reduction of hospitalization and post-operative pain. These are the advantages of robotic surgery introduced atUPMC Salvator Mundi International Hospital. A multidisciplinary team made up of six highly qualified professionals and the best Da Vinci technologies. To guarantee patients a faster recovery and less invasiveness: this is how the new department deals with bariatric, gynecological, urological, oncological and general surgery.
UPMC Salvator Mundi International Hospital, the floor to Luigi Macchitella, Medical Director
“Robotics are an essential aid for precision and less intrusive operations. Being able to significantly reduce the period of hospitalization and post-operative pain is a remarkable result. This is why we are pleased to inaugurate the new UPMC Salvator Mundi robotic surgery unit. A hospital of excellence that focuses on the best skills and cutting-edge technologies” he commented Luigi Macchitella, Medical Director of the facility.
Da Vinci robotics allows total control of the operation from a separate location from the operating field. This is thanks to three components: the surgical console, the patient trolley and the vision trolley.
The specialists part of UPMC Salvator Mundi’s robotic surgery team
- Prof. Antonio Carbone, specialist in Urology
- Prof. Mauro Cervigni, specialized in Urology and Gynecology
- Prof. Giuseppe Maria Ettorre, specialist in General and Vascular Surgery
- Prof. Pierluigi Marini, National President of the Italian Hospital Surgeons Association, specialist in General Surgery
- Prof. Ralf Senner, President of the European Center for Robotic Surgery for Obesity in Italy
- Dr. Fabrizio Signore, specialized in Gynecology and Obstetrics.
UPMC, what is it
UPMC is one of the leading academic health care and insurance systems in the United States; based in Pittsburgh (Pennsylvania), the Group operates directly in China, Ireland and Italy through UPMC International. UPMC’s clinical and healthcare management programs and services are globally recognized for their innovation; through close collaboration with the University of Pittsburgh, the Group is among the main international players in the field of scientific and biomedical research.
Present in Italy since 1997 with the Mediterranean Institute for Transplants and Highly Specialized Therapies (ISMETT), launched in Palermo in partnership with the Sicilian Region and today one of the three recognized Sicilian IRCCS, UPMC is building a health hub in Sicily and research: a new 250-bed hospital and the Ri.MED Foundation’s Center for Biotechnology and Biomedical Research (CBRB), a center of excellence for high-tech biotechnological and biomedical research projects launched in partnership with the Presidency of the Council, the CNR and the University of Pittsburgh.
UPMC’s other operations in Italy include three Hillman Cancer Centers (one of the largest global cancer networks) in Rome (UPMC HCC San Pietro FBF), in the province of Avellino (UPMC HCC Villa Maria) and within ISMETT. Also in Rome, in 2018 UPMC took over the private Salvator Mundi International Hospital.